PhoenixBio Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

444.36

356.10

400.25

398.06

355.12

339.05

449.15

Other Operating Income

0.00

Total Operating income

444.36

356.10

400.25

398.06

355.12

339.05

449.15

Raw Material Cost

90.64

90.83

90.61

72.55

110.67

126.67

113.80

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

1.24

1.16

1.24

1.37

1.27

1.28

1.32

Selling and Distribution Expenses

290.82

283.32

285.91

314.26

298.96

317.06

329.50

Other Expenses

-0.12

-0.14

-0.13

Total Expenditure (Excl Depreciation)

381.46

374.16

376.52

386.81

409.62

443.72

443.31

Operating Profit (PBDIT) excl Other Income

62.9

-18.1

23.700000000000003

11.299999999999999

-54.5

-104.7

5.8

Other Income

20.63

14.93

-1.84

-18.80

30.98

-42.87

20.65

Operating Profit (PBDIT)

92.72

4.88

29.20

1.22

-16.13

-141.35

32.34

Interest

1.24

1.16

1.24

1.37

1.27

1.28

1.32

Exceptional Items

0.00

-275.48

0.00

Gross Profit (PBDT)

353.72

265.27

309.65

325.51

244.46

212.39

335.35

Depreciation

9.19

8.01

7.31

8.77

7.38

6.20

5.85

Profit Before Tax

82.30

-4.29

20.66

-284.40

-24.79

-148.82

25.17

Tax

1.39

2.59

1.47

13.78

1.22

-0.92

2.02

Provisions and contingencies

0.00

Profit After Tax

80.91

-6.89

19.19

-298.17

-26.01

-147.90

23.15

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

80.91

-6.89

19.19

-298.17

-26.01

-147.90

23.15

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

80.91

-6.89

19.19

-298.17

-26.01

-147.90

23.15

Equity Capital

0.00

Face Value

0.0

Reserves

1,516.89

1,381.47

1,373.46

1,365.41

1,671.22

1,685.12

1,840.04

Earnings per share (EPS)

19.88

-1.69

4.74

-73.61

-6.42

-36.63

5.75

Diluted Earnings per share

19.88

-1.69

4.74

-73.61

-6.42

-36.63

5.75

Operating Profit Margin (Excl OI)

14.16%

-5.07%

5.93%

2.83%

-15.35%

-30.87%

1.3%

Gross Profit Margin

20.59%

1.04%

6.99%

-69.24%

-4.9%

-42.07%

6.91%

PAT Margin

18.21%

-1.93%

4.8%

-74.91%

-7.32%

-43.62%

5.15%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 24.80% vs -11.04% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 1,272.46% vs -135.94% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 813.86% vs -132.58% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of PhoenixBio Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

444.36

801.74

-357.38

-44.58%

Other Operating Income

0.00

Total Operating income

444.36

801.74

-357.38

-44.58%

Raw Material Cost

90.64

550.28

-459.64

-83.53%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

1.24

5.39

-4.15

-76.99%

Selling and Distribution Expenses

290.82

209.61

81.21

38.74%

Other Expenses

-0.12

-0.54

0.42

77.78%

Total Expenditure (Excl Depreciation)

381.46

759.90

-378.44

-49.80%

Operating Profit (PBDIT) excl Other Income

62.90

41.85

21.05

50.30%

Other Income

20.63

7.06

13.57

192.21%

Operating Profit (PBDIT)

92.72

86.81

5.91

6.81%

Interest

1.24

5.39

-4.15

-76.99%

Exceptional Items

0.00

Gross Profit (PBDT)

353.72

251.46

102.26

40.67%

Depreciation

9.19

37.90

-28.71

-75.75%

Profit Before Tax

82.30

43.52

38.78

89.11%

Tax

1.39

12.56

-11.17

-88.93%

Provisions and contingencies

0.00

Profit After Tax

80.91

30.96

49.95

161.34%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

80.91

30.96

49.95

161.34%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

80.91

30.96

49.95

161.34%

Equity Capital

0.00

Face Value

0.00

Reserves

1,516.89

3,556.95

-2,040.06

-57.35%

Earnings per share (EPS)

19.88

5.53

14.35

259.49%

Diluted Earnings per share

19.88

5.53

14.35

259.49%

Operating Profit Margin (Excl OI)

14.16%

5.22%

0.00

8.94%

Gross Profit Margin

20.59%

10.16%

0.00

10.43%

PAT Margin

18.21%

3.86%

0.00

14.35%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 44.44 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 24.80% vs -11.04% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 25.15% vs -20.54% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 8.09 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 1,272.46% vs -135.94% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 411.15% vs -96.97% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 7.21 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 813.86% vs -132.58% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 253.08% vs -210.82% in Dec 2024

Quarterly - Interest

Interest 0.12 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -7.69% vs 116.67% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 14.16%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024